Haisen Pharmaceuticals announced that the company plans to sign the "Haisen Pharmaceuticals New Factory Construction Project (Phase I) Investment Cooperation Agreement" with the Management Committee of Zhejiang Dongyang Economic Development Zone, intending to invest in building a new factory project within the Dongyang Economic Development Zone, with a total investment of no less than 2 billion yuan for Phase I, covering approximately 192.2 acres. The project will be used to produce active pharmaceutical ingredients such as aluminum glycine and atorvastatin calcium.